𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐚𝐠𝐞𝐧𝐜𝐢𝐞𝐬 𝐦𝐚𝐲 𝐫𝐞𝐪𝐮𝐢𝐫𝐞 𝐉𝐮𝐯𝐞𝐧𝐢𝐥𝐞 𝐀𝐧𝐢𝐦𝐚𝐥 𝐓𝐨𝐱𝐢𝐜𝐨𝐥𝐨𝐠𝐲 (𝐉𝐀𝐒) 𝐬𝐭𝐮𝐝𝐢𝐞𝐬 𝐛𝐞𝐟𝐨𝐫𝐞 𝐢𝐧𝐢𝐭𝐢𝐚𝐭𝐢𝐧𝐠 𝐩𝐚𝐞𝐝𝐢𝐚𝐭𝐫𝐢𝐜 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬—𝐞𝐬𝐩𝐞𝐜𝐢𝐚𝐥𝐥𝐲 𝐰𝐡𝐞𝐧 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐚𝐥 𝐭𝐨𝐱𝐢𝐜𝐢𝐭𝐢𝐞𝐬 𝐚𝐫𝐞 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝. When toxicities can’t be measured in early human studies, these preclinical safety assessments fill in the gaps. Each study for this is uniquely designed—tailored to your compound, patient age group, and organ systems of concern like neurological, reproductive, or skeletal. Our team has supported global sponsors with customized, GLP-compliant juvenile toxicity studies—combining regulatory expertise with a deep understanding of pediatric development. ✅ Over 20+ juvenile rodent studies completed successfully across varied dosing routes ✅ Case-by-case protocol planning ✅ Global registration alignment Looking for a CRO that speaks both science and strategy? Let’s design your next juvenile toxicology study together. Connect with our experts – [email protected]
